The Community and Academic Allergists Partnership in Education and Research (CA²PER) program is the College’s new initiative to foster collaboration between academic researchers and community-based allergists. The program aims to advance clinical research by addressing clinical questions important for improving allergy/immunology care.
We are pleased to announce that Wanda Phipatanakul, MD, MS, FACAAI, and Jordan E. Scott, MD, from Boston, Massachusetts, have been selected as our first grantees. Their project is titled, “Leveraging Artificial Intelligence to Predict Side Effects and Treatment Outcomes in Oral Immunotherapy (OIT) for Patients with Food Allergies.”
Wanda Phipatanakul
MD, MS, FACAAI
Academic PI
Jordan E. Scott, MD
Community PI
Look for the Spring/Summer College Advantage issue in your mailbox in May to learn more about their project. And join us in congratulating Drs. Phipatanakul and Scott for being selected for this unique opportunity.
Have a project idea you would like to get funded? Visit the CA²PER web page to see if you meet the criteria and consider submitting a proposal during the 2026 grant cycle.
